New cancer clinical trial: Pembrolizumab in Treating Participants With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules

Published on: August 16, 2018 at 12:00PM
Conditions:   Non-Small Cell Lung Carcinoma;   Pulmonary Nodule;   Stage I Lung Cancer AJCC v8;   Stage IA1 Lung Cancer AJCC v8;   Stage IA2 Lung Cancer AJCC v8;   Stage IA3 Lung Cancer AJCC v8;   Stage IB Lung Cancer AJCC v8;   Stage II Lung Cancer AJCC v8;   Stage IIA Lung Cancer AJCC v8;   Stage IIB Lung Cancer AJCC v8
Interventions:   Other: Best Practice;   Biological: Pembrolizumab;   Other: Quality-of-Life Assessment
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2OHqYtQ